Glivec 100 mg film-coated tablets
- Name:
Glivec 100 mg film-coated tablets
- Company:
Novartis Ireland Limited
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 01/07/20

Summary of Product Characteristics last updated on medicines.ie: 1/7/2020
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions. Click on this link to Download PDF directly
Novartis Ireland Limited

Company Products
Items Per Page :
1 - 0 of 118 items.Total: Infinity pages
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 1 July 2020 PIL
Reasons for updating
- Change to section 2 - pregnancy, breast feeding and fertility
Updated on 1 July 2020 SPC
Reasons for updating
- Change to section 4.6 - Pregnancy and lactation
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 7 April 2020 PIL
Reasons for updating
- Change to name of manufacturer
Updated on 23 August 2019 PIL
Reasons for updating
- Change to section 6 - date of revision
Updated on 4 April 2019 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Updated on 4 April 2019 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 20 July 2018 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 21 February 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 21 February 2017 PIL
Reasons for updating
- Change to section 4 - possible side effects
Updated on 22 June 2016 PIL
Reasons for updating
- Change to warnings or special precautions for use
Updated on 8 May 2015 PIL
Reasons for updating
- Change to side-effects
Updated on 29 April 2015 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Addition of black triangle
Updated on 23 April 2014 PIL
Reasons for updating
- Change to warnings or special precautions for use
Updated on 30 July 2013 PIL
Reasons for updating
- Change to date of revision
Updated on 27 September 2012 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change to drug interactions
- Change to MA holder contact details
Updated on 30 August 2011 PIL
Reasons for updating
- Change to side-effects
Updated on 10 April 2007 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change to, or new use for medicine
Updated on 10 January 2007 PIL
Reasons for updating
- Change to, or new use for medicine
Updated on 12 July 2006 PIL
Reasons for updating
- Change to side-effects
Updated on 2 November 2005 PIL
Reasons for updating
- Change to side-effects
- Change to dosage and administration
Updated on 25 August 2004 PIL
Reasons for updating
- New PIL for medicines.ie